Overall Fundamental outlook

Business Operations:

Sector: Basic Materials
Industry: Chemicals

Archean Chemical Industries Limited manufactures and sells specialty marine chemicals in India and internationally. It offers bromine for use in pharmaceuticals, agrochemicals, flame retardants, and water treatment products, as well as oil and gas, and energy storage industries; industrial salt for chloralkali chemical, food and beverage, water treatment, and oil and gas industries; and sulphate of potash, an inorganic salt for agrochemicals, medical, glass, cosmetics, etc. Industries. The company was founded in 2003 and is based in Chennai, India.

Revenue projections:

Revenue projections for ACI
Revenue projections for ACI

ACI's revenues are expected to fall below last year's, and this forecast tends to raise concerns among investors. A revenue drop can negatively impact the company's profitability, making investors more cautious about their positions due to the risks of declining financial performance.

Financial Ratios:

currentRatio 0.000000
forwardPE 22.159616
debtToEquity 14.782000
earningsGrowth -0.505000
revenueGrowth 0.051000
grossMargins 0.951730
operatingMargins 0.120970
trailingEps 11.870000
forwardEps 26.000000

ACI's Forward PE ratio is favorable, meaning the stock price aligns well with earnings and isn't overvalued. This allows room for growth, making it an attractive investment for those seeking potential upside while ensuring the stock is not overpriced.
ACI's low Debt-to-Equity ratio indicates that the company isn't over-leveraged, suggesting it maintains a healthy balance between debt and equity. This lowers financial risk and points to a stable financial foundation, reassuring investors of the company's financial health.
Archean Chemical Industries Limited's low growth in both earnings and revenue indicates the company's profits may decrease. This trend could signal a downturn in financial performance, suggesting that Archean Chemical Industries Limited might struggle to maintain its current profit levels.
With negative gross and operating margins, Archean Chemical Industries Limited is facing losses at both the production and operational levels. This signals significant financial strain and may indicate that the company is struggling to manage costs effectively.
Archean Chemical Industries Limited's forward EPS surpassing its trailing EPS signals that the company is anticipated to be more profitable this year than last. This growth expectation highlights Archean Chemical Industries Limited's potential for increased earnings and a stronger financial performance in the upcoming year.

Price projections:

Price projections for ACI
Price projections for ACI

The price of Archean Chemical Industries Limited has consistently been close to the lower limit of expectations. This trend may point to challenges in the company's performance, leading to concerns about its future growth potential.

Insider Transactions:

Insider Transactions for ACI
Insider Transactions for ACI


1 purchases of ACI stock were recorded, with market price of 627.5499877929688 per share.The period under consideration saw no buy transactions.ACI's current price levels have seen more selling than buying, which may indicate potential for further decline. If this trend continues, the stock could experience additional price drops, as selling pressure grows.

Recommendation changes over time:

Recommendations trend for ACI
Recommendations trend for ACI


Analysts have maintained a buy bias for Archean Chemical Industries Limited, which could prompt investors to consider the stock as a viable investment. With this positive outlook, Archean Chemical Industries Limited is positioned as an attractive option for those looking to park their money in a stable and potentially lucrative company.